InfuSystem Holdings (INFU) Share-based Compensation (2010 - 2026)
InfuSystem Holdings (INFU) posted Share-based Compensation of $165000.0 for Q1 2026, down 95.04% on a QoQ basis from $3.3 million in Q4 2025, and down 85.11% year-over-year from $1.1 million in Q1 2025.
InfuSystem Holdings (INFU) Share-based Compensation (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Share-based Compensation history runs 13 years deep, the most recent figure standing at $165000.0 for Q1 2026.
- Quarterly Share-based Compensation fell 85.11% year-over-year to $165000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 34.27% YoY) and the FY2025 annual result came in at $4.4 million, down 2.17% from the prior year.
- Share-based Compensation was $165000.0 for Q1 2026 at InfuSystem Holdings, down from $3.3 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.3 million in Q4 2025 and bottomed at -$733000.0 in Q3 2025.
- A 5-year average of $993352.9 and a median of $661000.0 in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation surged 3757.63% — and 2025, when it sank 127.64%.
- InfuSystem Holdings' Share-based Compensation stood at $3.1 million in 2022, then tumbled by 59.23% to $1.3 million in 2023, then slipped by 7.14% to $1.2 million in 2024, then jumped by 181.0% to $3.3 million in 2025, then slumped by 95.04% to $165000.0 in 2026.
- Business Quant data shows INFU's Share-based Compensation at $165000.0 in Q1 2026, $3.3 million in Q4 2025, and -$733000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 165,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 165,000.00 |
| Mar 31, 2026 | 165,000.00 |
| Dec 31, 2025 | 3.33 Mn |
| Dec 31, 2025 | 3.33 Mn |
| Sep 30, 2025 | -733,000.00 |
| Sep 30, 2025 | -733,000.00 |
| Jun 30, 2025 | 661,000.00 |
| Jun 30, 2025 | 661,000.00 |
| Mar 31, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 259,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Dec 31, 2023 | 1.28 Mn |
| Dec 31, 2023 | 1.28 Mn |